Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
NAR Molecular Medicine|April 13, 2026
Human pneumovirus induces IFN-dependent expression of the immune-responsive gene 1 and is inhibited by 4-octyl itaconate in human macrophagesAlix S Spahn, Kristin Rian, Alexandre Gidon, et al.
NAR Molecular Medicine|April 13, 2026
Functional role of Galectin-9 in nucleic acid trafficking and transcription post-electrotransfectionYifei Wang, Justin Sylvers, Fan Yuan
NAR Molecular Medicine|June 29, 2026
A yeast recombination system recapitulates the length polymorphism of a microsatellite implicated in human social behaviorCatie E Kean, Elina A Radchenko, Noah M Lindenbaum, et al.
NAR Molecular Medicine|June 29, 2026
Tetrahedral DNA nanostructure-delivered suppressor tRNA ameliorates nephropathy in COL4A5 nonsense mutation-mediated Alport syndrome miceJingru Lv, Ying Li, Dean Hong, et al.
NAR Molecular Medicine|October 28, 2024
C G composition in transposon-derived genes is increased in FXD with perturbed immune systemTamaki Suganuma, Huzaifa Hassan, Madelaine Gogol, et al.
NAR Molecular Medicine|September 3, 2025
Mechanism and spectrum of inhibition of viral polymerases by 2'-deoxy-2'-β-fluoro-4'-azidocytidine or azvudineHery W Lee, Egor P Tchesnokov, Laura J Stevens, et al.
NAR Molecular Medicine|April 13, 2026
EBV genome analysis in multiple sclerosis shows extensive viral diversity and links to autoimmunityJoonas Lehikoinen, Leo Hannolainen, Osma S Rautila, et al.
NAR Molecular Medicine|June 10, 2026
MCVAE-based multi-omic anomaly detection in Fragile X SyndromeWassila Khatir, Marco Lorenzi, Irene Balelli, et al.
NAR Molecular Medicine|May 22, 2026
Correction to 'Integrating transcriptomics and proteomics to assess antisense oligonucleotide safety and efficacy: a time-resolved approach'
NAR Molecular Medicine|June 1, 2026
Evolutionary refinement of the ZIKV 5' UTR dictates a trade-off between RNA stability and promoter accessibilityAlex B Wang, Quinn H Abram, Carolina Camargo, et al.
Pageof 12